Characterization of Multidrug Resistant Extended-Spectrum Beta-Lactamase-Producing Escherichia coli among Uropathogens of Pediatrics in North of Iran

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Rezai, Mohammad Sadegh ^a   Salehifar, Ebrahim ^a   Rafiei, Alireza ^b   Langaee, Taimour ^c   Rafati, Mohammadreza ^a   Shafahi, Kheironesa ^a   Eslami, Gohar ^a,c  

^a MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; BETA LACTAMASE CTX M; CARBAPENEM DERIVATIVE; CEFIXIME; CEFOTAXIME; CEFTRIAXONE; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; IMIPENEM; ANTIINFECTIVE AGENT; BETA LACTAM; BETA LACTAMASE; BETA-LACTAMASE TEM-1;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; GENOTYPE; IRAN; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PEDIATRICS; POLYMERASE CHAIN REACTION; CHILD; ENZYMOLOGY; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; GENETICS; HUMAN; MALE; MICROBIOLOGY; PATHOGENICITY; PRESCHOOL CHILD; URINARY TRACT INFECTIONS;

ESCHERICHIA COLI;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; BETA-LACTAMS; CARBAPENEMS; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; IRAN; MALE; URINARY TRACT INFECTIONS;

EID: 84929646397     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/309478     Document Type: Article

References (40)

1. N. Girish, K. Saileela, and S. K. Mohanty, "Extended spectrum beta-lactamase producing Klebsiella pneumoniae and Escherichia coli in neonatal intensive care unit," Journal of Bacteriology & Parasitology, vol. 3, p. 2, 2012.
2. A. Poulou, E. Grivakou, G. Vrioni et al., "Modified CLSI extended-spectrum β-lactamase (ESBL) confirmatory test for phenotypic detection of ESBLs among Enterobacteriaceae producing various β-lactamases," Journal of Clinical Microbiology, vol. 52, no. 5, pp. 1483-1489, 2014.
3. M. A. Bhat, S. Sageerabanoo, R. Kowsalya, and G. Sarkar, "The occurrence of CTX-M3 type extended spectrum beta lactamases among Escherichia coli causing urinary tract infections in a tertiary care hospital in puducherry," Journal of Clinical and Diagnostic Research, vol. 6, no. 7, pp. 1203-1206, 2012.
4. A. Bhattacharjee, M. R. Sen, P. Prakash, A. Gaur, and S. Anupurba, "Increased prevalence of extended spectrum βlactamase producers in neonatal septicaemic cases at a tertiary referral hospital," Indian Journal of Medical Microbiology, vol. 26, no. 4, pp. 356-360, 2008.
5. P. A. Bradford, "Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat," Clinical Microbiology Reviews, vol. 14, no. 4, pp. 933-951, 2001.
6. D. L. Paterson, K. M. Hujer, A. M. Hujer et al., "Extended-spectrum β-lactamases in klebsiella pneumoniae bloodstream isolates from seven countries: dominance and widespread prevalence of SHV- and CTX-M-Type β-lactamases," Antimicrobial Agents and Chemotherapy, vol. 47, no. 11, pp. 3554-3560, 2003.
7. P. Lal, A. Kapil, B. K. Das, and S. Sood, "Occurrence of TEM & SHV gene in extended spectrum β-lactamases (ESBLs) producing Klebsiella sp. isolated from a tertiary care hospital,"Indian Journal of Medical Research, vol. 125, no. 2, pp. 173-178, 2007.
8. J. Rodríguez-Baño, M. D. Navarro, L. Romero et al., "Clinical and molecular epidemiology of extended-spectrum β-lactamase. Producing Escherichia coli as a cause of nosocomial infection or colonization: implications for control," Clinical Infectious Diseases, vol. 42, no. 1, pp. 37-45, 2006.
9. J. Kim, S. G. Hong, I. K. Bae et al., "Emergence of Escherichia coli sequence type ST131 carrying both the bla GES-5 and bla CTX-M-15 genes," Antimicrobial Agents and Chemotherapy, vol. 55, no. 6, pp. 2974-2975, 2011.
10. S. A. Jemima and S. Verghese, "Multiplex PCR for blaCTXM & blaSHV in the extended spectrum beta lactamase (ESBL) producing gram-negative isolates," Indian Journal of Medical Research, vol. 128, no. 3, pp. 313-317, 2008.
11. E. Ruppé, S. Hem, S. Lath et al., "CTX-M β-lactamases in Escherichia coli from community-acquired urinary tract infections, Cambodia," Emerging Infectious Diseases, vol. 15, no. 5, pp. 741-748, 2009.
12. I. Shukla, R. Tiwari, and M. Agrawal, "Prevalence of extended spectrum β-lactamasee producing Klebsiella pneumoniae in a tertiary care hospital," Indian Journal of Medical Microbiology, vol. 22, no. 2, pp. 87-91, 2004.
13. T. B. Y. Liem, M. Filius, P. D. van der Linden, R. Janknegt, S. Natsch, and A. G. Vulto, "3.1 Changes in antibiotic use in Dutch hospitals over a 6-year period: 1997-2002," in Antimicrobial Drug Use in Hospitalized Children, vol. 63, p. 60, 2011.
14. J. Oteo, V. Bautista, N. Lara et al., "Parallel increase in community use of fosfomycin and resistance to fosfomycin in extended-spectrum β-lactamase (ESBL)-producing Escherichia coli," Journal of Antimicrobial Chemotherapy, vol. 65, no. 11, pp. 2459-2463, 2010.
15. Liaison Representatives, "Practice parameter: the diagnosis, treatment, and evaluation of the initial urinary tract infection in febrile infants and young children. American Academy of Pediatrics. Committee on Quality Improvement. Subcommittee on Urinary Tract Infection," Pediatrics, vol. 103, no. 4, pp. 843-852, 1999.
16. F. R. Cockerill, Performance Standards for Antimicrobial Susceptibility Testing: Twenty-First Informational Supplement, Clinical and Laboratory Standards Institute (CLSI), 2011.
17. P. Wayne, "Performance standards for antimicrobial susceptibility testing. Twenty firt informational supplement," CLSI Document M100-S21, Clinical and Laboratory Standards Institute, 2011.
18. A. Manoharan, K. Premalatha, S. Chatterjee, and D. Mathai, "Correlation of TEM, SHV and CTX-M extended-spectrum beta lactamases among Enterobacteriaceae with their in vitro antimicrobial susceptibility, vol. 29, no. 2, pp. 161-164, 2011.
19. L. Poirel, I. Le Thomas, T. Naas, A. Karim, and P. Nordmann, "Biochemical sequence analyses of GES-1, a novel class A extended-spectrum β-lactamase, and the class 1 integron In52 from Klebsiella pneumoniae," Antimicrobial Agents and Chemotherapy, vol. 44, no. 3, pp. 622-632, 2000.
20. M. Y. Alikhani, Z. Karimi Tabar, F. Mihani et al., "Antimicrobial resistance patterns and prevalence of blaPER-1 and blaVEB-1 genes among ESBL-producing Pseudomonas aeruginosa isolates in West of Iran," Jundishapur Journal of Microbiology, vol. 7, no. 1, Article ID e8888, 2014.
21. S. Benenson, S. Navon-Venezia, Y. Carmeli et al., "Carbapenem-resistant Klebsiella pneumoniae endocarditis in a young adult. Successful treatment with gentamicin and colistin," International Journal of Infectious Diseases, vol. 13,no. 5, pp. e295-e298, 2009.
22. Y. H. Lee, B. Cho, I. K. Bae, C. L. Chang, and S. H. Jeong, "Klebsiella pneumoniae strains carrying the chromosomal SHV-11 β-lactamase gene produce the plasmid-mediated SHV-12 extended-spectrum β-lactamase more frequently than those carrying the chromosomal SHV-1 β-lactamase gene," Journal of Antimicrobial Chemotherapy, vol. 57, no. 6, pp. 1259-1261, 2006.
23. B. Kochaksaraii, N. A. Omran, N. Javid, F. Shakeri, M. Yazdi, and E. Ghaemi, "Extended spectrum beta lactamase producing E.coli isolated from Gorgan, North of Iran," Medical Laboratory Journal, vol. 6, no. 1, 2012.
24. M. Moosavian and B. Deiham, "Distribution of TEM, SHV and CTX-MGenes among ESBL-producing Enterobacteriaceae isolates in Iran," African Journal of Microbiology Research, vol. 6, pp. 5433-5439, 2012.
25. L. Arbabi, M. Rahbar, M. Jabbari et al., "Extended-spectrum beta-lactamase-producing E. coli and Klebsiella pneumoniae isolated from urinary tract infections in Milad Hospital, Tehran, Iran," HealthMED Journal, 2012.
26. F. Shahcheraghi, V. S. Nikbin, and M. M. Feizabadi, "Prevalence of ESBLs genes among multidrug-resistant isolates of pseudomonas aeruginosa isolated from patients in Tehran,"Microbial Drug Resistance, vol. 15, no. 1, pp. 37-39, 2009.
27. S. Ananthan and A. Subha, "Cefoxitin resistance mediated by loss of a porin in clinical strains of Klebsiella pneumoniae and Escherichia coli," Indian Journal of Medical Microbiology, vol. 23, no. 1, pp. 20-23, 2005.
28. C. Branger, O. Zamfir, S. Geoffroy et al., "Genetic background of Escherichia coli and extended-spectrum β-lactamase type,"Emerging Infectious Diseases, vol. 11, no. 1, pp. 54-61, 2005.
29. S. Babypadmini and B. Appalaraju, "Extended spectrum β-lactamases in urinary isolates of Escherichia coli and Klebsiella pneumoniae - prevalence and susceptibility pattern in a tertiary care hospital," Indian Journal of Medical Microbiology, vol. 22, no. 3, pp. 172-174, 2004.
30. S. Swerkersson, U. Jodal, C. Åhrén, and S. Hansson, "Urinary tract infection in small outpatient children: the influence of age and gender on resistance to oral antimicrobials," European Journal of Pediatrics, vol. 173, no. 8, pp. 1075-1081, 2014.
31. S. Benenson, S. Navon-Venezia, Y. Carmeli et al., "Carbapenem-resistant Klebsiella pneumoniae endocarditis in a young adult. Successful treatment with gentamicin and colistin," International Journal of Infectious Diseases, vol. 13,no. 5, pp. e295-e298, 2009.
32. Y.-H. Ku, M.-F. Lee, Y.-C. Chuang, C.-C. Chen, and W.-L. Yu, "In vitro activity of colistin sulfate against Enterobacteriaceae producing extended-spectrum beta lactamases," Journal of Microbiology, Immunology and Infection, 2014.
33. A. Walkty, M. DeCorby, K. Nichol, J. A. Karlowsky, D. J. Hoban, and G. G. Zhanel, "In vitro activity of colistin (polymyxin E) against 3,480 isolates of gram-negative bacilli obtained from patients in Canadian hospitals in the CANWARD study, 2007-2008," Antimicrobial Agents and Chemotherapy, vol. 53, no. 11, pp. 4924-4926, 2009.
34. A. A. Kader and A. K. Kumar, "Prevalence of extended spectrum β-lactamase among multidrug resistant gram-negative isolates from a general hospital in Saudi Arabia," Saudi Medical Journal, vol. 25, no. 5, pp. 570-574, 2004.
35. F. Shahcheraghi, S. Nasiri, and H. Noveiri, "Detection of extended-spectrum β-lactamases (ESBLs) in Escherichia coli,"Iranian Journal of Clinical Infectious Diseases, vol. 4, no. 2, pp. 65-70, 2009.
36. P. M. Hawkey, "Prevalence and clonality of extended-spectrum β-lactamases in Asia," Clinical Microbiology and Infection, vol. 14, no. 1, pp. 159-165, 2008.
37. E. Salehifar, M. M. Nasehi, G. Eslami, S. Sahraei, and R. Alizadeh-Navai, "Determination of antibiotics consumption in Buali-Sina pediatric Hospital, Sari 2010-2011," Iranian Journal of Pharmaceutical Research, vol. 13, no. 3, p. 995, 2014.
38. G. L. French, K. P. Shannon, and N. Simmons, "Hospital outbreak of Klebsiella pneumoniae resistant to broad-spectrum cephalosporins and β-lactam-β-lactamase inhibitor combinations by hyperproduction of SHV-5 β-lactamase," Journal of Clinical Microbiology, vol. 34, no. 2, pp. 358-363, 1996.
39. M. Edelstein, M. Pimkin, I. Palagin, I. Edelstein, and L. Stratchounski, "Prevalence and Molecular Epidemiology of CTX-M Extended-Spectrum β-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae in Russian Hospitals," Antimicrobial Agents and Chemotherapy, vol. 47, no. 12, pp. 3724-3732, 2003.
40. N. Mendonça, J. Leitão, V. Manageiro, E. Ferreira, and M. Caniça, "Spread of extended-spectrum β-lactamase CTX-M-producing Escherichia coli clinical isolates in community and nosocomial environments in Portugal," Antimicrobial Agents and Chemotherapy, vol. 51, no. 6, pp. 1946-1955, 2007.